Search

Author/Creator Heine, Robert J

1. Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial. Issue 4 (October 2016)

Authors:
van Raalte, Daniël H; Bunck, Mathijs C; Smits, Mark M; Hoekstra, T; Cornér, Anja; Diamant, Michaela; Eliasson, Bjorn; Marja-RiittaTaskinen, ; Heine, Robert J; Smith, Ulf; HanneleYki-Järvinen, ; Mari, Andrea
Journal:
European journal of endocrinology
Issue:
Volume 175:Issue 4(2016)
Page Start:
345
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Time to insulin initiation and long-term effects of initiating insulin in people with type 2 diabetes mellitus: the Hoorn Diabetes Care System Cohort Study. Issue 5 (May 2016)

Authors:
Mast, Ruth; Danielle Jansen, A P; Walraven, Iris; Rauh, Simone P; van der Heijden, Amber A W A; Heine, Robert J; Elders, Petra J M; Dekker, Jacqueline M; Nijpels, Giel; Hugtenburg, Jacqueline G
Journal:
European journal of endocrinology
Issue:
Volume 174:Issue 5(2016)
Page Start:
563
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial. Issue 10313 (13th November 2021)

Authors:
Del Prato, Stefano; Kahn, Steven E; Pavo, Imre; Weerakkody, Govinda J; Yang, Zhengyu; Doupis, John; Aizenberg, Diego; Wynne, Alan G; Riesmeyer, Jeffrey S; Heine, Robert J; Wiese, Russell J; Ahmann, Andrew J; Arora, Samir; Ball, Eric M; Calderon, Rafael B; Butuk, David J; Chaychi, Leila; Chen, Mic...
Journal:
Lancet
Issue:
Volume 398:Issue 10313(2021)
Page Start:
1811
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗